Free Trial
LON:PXS

Provexis (PXS) Share Price, News & Analysis

GBX 0.90 +0.10 (+11.80%)
As of 12:25 PM Eastern

About Provexis Stock (LON:PXS)

Advanced

Key Stats

Today's Range
0.71
▼
0.94
50-Day Range
0.76
▼
1.20
52-Week Range
0.56
▼
1.55
Volume
1.09 million shs
Average Volume
1.75 million shs
Market Capitalization
£21.11 million
P/E Ratio
N/A
Dividend Yield
5.06%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function. The company sells its products through distributors and online channels. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

Receive PXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Provexis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PXS Stock News Headlines

Provexis (PXS) AI Stock Analysis
Provexis PLC Full Year Sales Decline
Top Trader Reveals Stunning Black Friday Deal
Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel
AIM Market Roundup: Ramsdens, Provexis, Pulsar Helium
AIM Market Roundup: Provexis, Geo Exploration, Sabien
See More Headlines

PXS Stock Analysis - Frequently Asked Questions

Provexis' stock was trading at GBX 0.90 at the beginning of 2026. Since then, PXS stock has increased by 0.0% and is now trading at GBX 0.90.

Provexis plc (LON:PXS) posted its quarterly earnings data on Thursday, October, 1st. The company reported GBX (0.02) earnings per share for the quarter. Provexis had a negative trailing twelve-month return on equity of 44.68% and a negative net margin of 39.76%.

Shares of PXS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Company Calendar

Last Earnings
10/01/2026
Today
11/13/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
LON:PXS
CIK
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£619.15 thousand
Net Margins
-39.76%
Pretax Margin
N/A
Return on Equity
-44.68%
Return on Assets
-56.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.79
Quick Ratio
6.21

Sales & Book Value

Annual Sales
£1.26 million
Price / Sales
16.70
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
GBX 0.01 per share
Price / Book
104.92

Miscellaneous

Outstanding Shares
2,345,891,000
Free Float
N/A
Market Cap
£21.11 million
Optionable
Not Optionable
Beta
0.66
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (LON:PXS) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners